Global auto-injectors market was valued at USD 665.0 million in 2013 and is expected to grow at a CAGR of 18.6% from 2014 to 2020, to reach USD 2,503.4 million in 2020
On the other hand, the high prices associated with auto-injectors are restricting patients in developing economies from purchasing them, limiting the overall development of the global auto-injectors market, reports the study.The report analyzes the global auto-injectors market on the basis of products, applications, manufacturing designs, and regional distribution.Based on products, prefilled auto-injectors led the global auto-injectors market on account of their ease of usage and increasing patient awareness regarding these devices, while by application, the anaphylaxis market segment dominated the global market owing to the high prevalence of anaphylaxis. The market is expected to register the fastest growth among application segments of the auto-injectors market during the forecast period.
Browse the full Auto-injectors Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 report at http://www.transparencymarketresearch.com/global-auto-injectors-market.html
On the basis of manufacturing design, the standardized auto-injectors market segment led the global market in 2013. However, the customized auto-injectors market is projected to report the fastest growth over the forecast period, states the report.On regional basis, the auto injectors market in North America ranked first among all the regional markets, accounting for 70% of the overall industry in 2013.
High incidence of multiple sclerosis and anaphylaxis, coupled with favorable reimbursement policies, has fueled the auto-injectors market in the region. However, analysts at TMR expect the market in Asia Pacific to register the fastest growth during the forecast period.Apart from this, the report identifies the increasing prevalence of rheumatoid arthritis and food allergies in developing economies as potential growth drivers of the auto-injectors markets in Asia Pacific and the Rest of the World.
The global auto-injectors market is concentrated in nature. The major companies profiled in this report are Antares Pharma Inc., Biogen Idec, Becton, Dickinson & Co., Mylan, Inc., Pfizer, Inc., Novartis International AG, Sanofi, Unilife Corp., Scandinavian Health Ltd., and Ypsomed Holding AG.On account of the massive demand for Auvi-Q and EpiPen auto-injectors, Sanofi and Mylan Inc.lead the standardized auto-injectors segment of the global market, whereas the customized auto-injectors segment is led by the SHL Group, which offers a wide range of pre-filled customized auto-injectors.
Requesting for Sample : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4199
Innovation is the key driver of the global auto-injectors market, according to the publication. Auto-injector manufacturers continuously work upon developing new and effective auto-injectors for the treatment of various diseases in order to gain a competitive edge over peers.
For more information:Make an Inquiry about this report HERE!
Category: Market Research Publishers and RetailersCompany about: TMR provides a range of marketing and business research solutions designed for your specific needs. From off-the-shelf syndicated business And market research to made-to-order custom research, we serve our clients to fulfill their immediate as well as ongoing research requirements. We specialize in the following areas: Syndicated Research Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemical, energy, food & beverage ...